StemMedical A/S: Financial statements 2015
CVR: 35852808
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
StemMedical A/S (CVR 35852808) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -269,424 and a net result of DKK -306,200 compared with DKK -197,505 the year before. Equity in the 2015 report amounted to DKK 1,896,540. The solvency ratio was 97.8%.
- Gross Profit
- DKK -269,424
- Profit/Loss
- DKK -306,200
- Equity
- DKK 1,896,540
- Total Assets
- DKK 1,938,392
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -269K | -306K | 1.9M | - |
| 2014 | - | -80K | -198K | -104K | - |
Official annual report
How creditworthy is StemMedical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
StemMedical A/S has published its annual report for 2014. Gross profit came to DKK -79,971, and the net result was DKK -197,505.
As of February 16, 2015, Bo Jønsson has joined the board of directors of StemMedical A/S.
As of February 16, 2015, Nis Isak Alstrup has joined the board of directors of StemMedical A/S.
As of February 16, 2015, Anders Christian Wolf Kølle has joined the board of directors of StemMedical A/S.
As of February 16, 2015, Christian Nissen Riisberg has joined the board of directors of StemMedical A/S.
As of February 15, 2015, LUNI REVISION I/S has been appointed auditor of StemMedical A/S.
As of February 15, 2015, LUNI REVISIONS ANPARTSSELSKAB has stepped down as auditor of StemMedical A/S.
About StemMedical A/S
StemMedical A/S was a Danish company of the type Aktieselskab based in Søborg, founded in 2014. The company has been dissolved on 25 September 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named STEMFORM A/S and STEMFORM ApS. The company has 18 employees (2024). In 2022, the company reported a gross profit of DKK -7,902,529 and a net result of DKK -18,876,055 compared with DKK -13,221,367 the year before. Equity in the 2022 report amounted to DKK 12,392,865.